SU811750A1 - Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same - Google Patents
Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same Download PDFInfo
- Publication number
- SU811750A1 SU811750A1 SU792810010A SU2810010A SU811750A1 SU 811750 A1 SU811750 A1 SU 811750A1 SU 792810010 A SU792810010 A SU 792810010A SU 2810010 A SU2810010 A SU 2810010A SU 811750 A1 SU811750 A1 SU 811750A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- bis
- monomers
- aliphatic diols
- producing
- polyurethanes
- Prior art date
Links
Description
Изобретение относитс к синтезу новых химических Лединений - бискарбонатов общей формулы: х-о-с-о-к-о-с-сж. где В сНг-сН2 сн -СНг сН2-сн-, X-4O W2;- p --N02-, ci .ei Cl Gl и choco6 их получени . Активированные бис карбонаты алифатических диолов вл ютс высокореакционными бифункциональными соединени ми и могут быть использованы дл получени высокомолекул рных поли уретанов и поликарбонатов. Указанные соединени , их свойства и способ получени в .литературе не описаны. . Известны Cl 3 бифункциональные соJeдйнeни на основе алифатических дио1лов - бис-хлорформиаты диолов, используемые в качестве мономеров в услови х поликонденсации дл синтеза поли уретанов и поликарбонатов. Использование бис-хлорформиатов в i качестве мономеров в поликонденсации pЯJ недостатков 2 3 « -бис-хлорформиаты токсичные веществ вызывание коррозию; -они легко гидролизуютс и их хранение затруднено , при гидролизе выдел ютс 2 моль двуокиси углерода и 2 «ОЛЬ .хлористого водорода и необходимо учитывать опасность повышени давани ; -бис-хлорформиаты практически не пригодны дл синтеза полиуретанов поликонденсацией в растворе, они реагируют со многими органическими растворител ми, что затрудн ет подбор растворителей дл проведени поликонденсации; 8П7 5 «О 15 20 25 02 -бис-хлорфррмиаты бурно реагируют также с третичными аминами, используемыми в качестве акцептора хлористого водорода, что приводит к гибели функциональных групп и образованию низкомолекул рных полимеров - при синтезе бис-хлорформиатов различных диолов необходимо многократное использование фосгена, что осложн ет технологию процесса; -большинство бис-хлорформиатов алифатических диолов, - жидкости, что создает неудобства при работе с ними, они имеют высокие температуры кипеии и очищаютс лишь перегонкой в вакууме; -при синтезе р д бис-хлорформиатов, с короткой углеводородной цепью в качестве побочных продуктов образуютс циклические карбонаты, что приводит к нарушению эквимолекул рности при проведении реакции поликонденсации. Целью изобретени вл етс синтез активированных бис-карбонатов алифатических диолов, которые могут быть использованы дл получени высокомолекул рных полиуретанов и поликарбонатов ., Поставленна цель достигаетс ноо структурой химических соединений бщей формулы: x-0-c-o-K-o-c-oXi гЗе R -cHrCH2-cH2-v -сНз СН2-СН2-СНСГ С1 Указанные соединени получают заимодействием бис-хлорформиата алиатического диола с соединением, вы ранным ,из групп: нитрофенол, динитофенол , трихлорфенол, пентахлорфенрл, ли алифатический диол с хлорформиа3 том соединений из той же группы , в среде Органического растворител в присутствии третичного амина в каО /-Л и ОглО/ °This invention relates to the synthesis of new chemical compounds - bis-carbonates of the general formula: x-o-c-c-c-s-comp. where b cnH cH2 cn cCHg cH 2 cn, X-4O W2; - p -N02-, ci .ei Cl Gl and choco6 are used to obtain them. Activated bis carbonates of aliphatic diols are highly reactive bifunctional compounds and can be used to produce high molecular weight polyurethanes and polycarbonates. These compounds, their properties and the method of their preparation are not described in the literature. . Cl 3 bifunctional compounds based on aliphatic dioles — diols bis chloroformates, used as monomers under polycondensation conditions for the synthesis of polyurethanes and polycarbonates are known. The use of bis-chloroformates as i monomers in the polycondensation of the pIJ deficiencies of 2 3 "-bis-chloroformates toxic substances causing corrosion; - they hydrolyze easily and their storage is difficult, during hydrolysis 2 moles of carbon dioxide and 2 "OLA of hydrogen chloride are released and the danger of pressure increase must be taken into account; - bis-chloroformates are practically unsuitable for the synthesis of polyurethanes by solution polycondensation, they react with many organic solvents, which makes it difficult to select solvents for carrying out polycondensation; 8P7 5 "О 15 20 25 02 -bis-chlorofrmimates also react violently with tertiary amines used as an acceptor of hydrogen chloride, which leads to the death of functional groups and the formation of low-molecular polymers - the synthesis of bis-chloroformates of various diols requires repeated use of phosgene, which complicates the process technology; Most of the bis-chloroformates of aliphatic diols, liquids, which cause inconvenience in working with them, they have high boiling points and are purified only by distillation in a vacuum; - during the synthesis of a series of bis-chloroformates, cyclic carbonates are formed as by-products with a short hydrocarbon chain, which leads to a violation of the equimolecularity during the polycondensation reaction. The aim of the invention is the synthesis of activated bis-carbonates of aliphatic diols, which can be used to obtain high molecular weight polyurethanes and polycarbonates. The goal is achieved by the structure of the chemical compounds of the formula: x-0-coKoc-oXi gze R -cHrCH2-cH2-v -sHz CH2-CH2-SNSH C1 These compounds are obtained by the interaction of an aliatic diol bis-chloroformate with a compound made from the following groups: nitrophenol, dinitophenol, trichlorophenol, pentachlorophenrel, or an aliphatic diol with chloroformate 3 of the compounds from t oh same group, in the environment of an Organic solvent in the presence of a tertiary amine in kaO / -L and Oglo / °
К 2,783 г (0,02 моль) п-нитрофенола при комнатной температуре прили- ю веют 30 мл сухого хлорбензола и 2,8мл {0,02 моль) триэтиламина. После пол1 эго растворени п-нитрофенола раствор охлаж;с ают до -15 и медленно , аокапл м (риливакп раствор js 7,0t г (о,01 моль )бисхлорформиата li,3 пропандиола в 5 мл хлорбензола. После доьавлени всего количества бисх Т-урформиата реакционную смесь перемешивают 15 мин,после чего охлаждение 2о30 ml of dry chlorobenzene and 2.8 ml {0.02 mol) of triethylamine are added to 2.783 g (0.02 mol) of p-nitrophenol at room temperature. After the complete dissolution of p-nitrophenol, the solution is cooled down to -15 and slowly, mixed (the solution js 7.0t g (o, 01 mol) of li bischloroformate, 3 propanediol in 5 ml of chlorobenzene. After the total amount of bis -urformate, the reaction mixture is stirred for 15 min, after which the cooling 2o
ОоOoh
51 « /51 "/
;О о-с-о-(сн21з-о-с-о- р. тч Щ Синтез осуществл ют в соответствии - методикой, приведенной в примере 1, с той разницей, что вместо п-нитроФенола берут 2,-динитрофенол.Продукт получаетс в осадке в смеси с сол нокислым триэтиламином, его от фильтровывают, промывают спиртом и Синтез осуществл ют в соответствии с. методикой, приведенной в примере 1, с той разницей, что вместо п-нитрофенола берут 2,4,6-трихлорфенол. Продукт реакции - в растворе, поэтому реакционную смесь отфильтровывают от .выгнавшего сол нокислого триэтиламина, осадок промывают дважды небольшими О - oy-Q- -(() Cl Cl Синтез осуществл ют в соответствии с методикой, приведенной в примере 1, с той разницей, что вместо п-нитро- , фенола берут пентахлорФенол. Продукт выпадает из реакционного раствора вместе с сол нокислым триэтиламином, осадок отфильтровывают, промывают этиснимают и перемешивание продолжают при комнатной температуре в течение |1 ч. Продукт вместе с сол нокислым триэтиламином выпадает в осадок, который отфильтровывают и дл удалени сол нокислого триэтиламина промывают этиловым спиртом и, сушат. Получают . практически чистое белое кристаллическое вещество с т.пл. 131132°С. Выход после перекристаллизации мз толуола т.пл.132-133°С. Приме-р 2. 8П750 чес1йр катализатора и акцептора хлоригтого водорода при -15 - . . Пример 1. о 1 , сушат. Получают практически чистое, белое кристаллическоевещество с Т.пл. 87-88 е, выход 65%, после перекристаллизации из смеси толуола с :гексаном т.пл. . П р и м е р 3. ) з-о-с-о ( по 5 мл ) порци ми хлорбензола. Объединенный фильтр упаривают в вакууме. Получают белое кристаллическое вещество с т.пл. 107-110°С, выход 50, после перекристаллизации из гексана т.пл. 110-112 С. Пример t. С1 С1 -Q. СГ С1 ловым спиртом и сушат. Получают белое кристаллическое, практически чистое вещество с т.пл. , выход 75. После перекристаллизации из смеси толуола с гексаном т.пл. 17б-178 с. Примерз.; About o-c-o- (sn 213-o-c-o-r. Tch W. Synthesis is carried out in accordance with the procedure described in Example 1, with the difference that 2, -dinitrophenol is taken instead of p-nitro-phenol. Product is obtained in the sediment in a mixture with hydrochloric triethylamine, it is filtered, washed with alcohol, and the synthesis is carried out in accordance with the procedure described in example 1, with the difference that 2,4,6-trichlorophenol is taken instead of p-nitrophenol. reactions in solution, therefore, the reaction mixture is filtered from the expelled triethylamine hydrochloride, the precipitate is washed twice We use small O - oy-Q- - (() Cl Cl Synthesis is carried out in accordance with the procedure described in Example 1, with the difference that pentachlorophenol is taken instead of p-nitro and phenol. The product falls out of the reaction solution along with the salt triethylamine, acidic precipitate is filtered off, washed with ethinuid and stirring is continued at room temperature for 1 hour. The product together with triethylamine hydrochloride precipitates, which is filtered off and washed with ethyl alcohol to remove triethylamine and dried. Get it. almost pure white crystalline substance with so pl. 1,31132 ° C. The output after recrystallization mz toluene, mp 132-133 ° C. Example 2. 8P750 car1 catalyst and hydrogen chlorine acceptor at -15 -. . Example 1. about 1, dried. An almost pure, white crystalline substance is obtained with m.p. 87-88 e, yield 65%, after recrystallization from a mixture of toluene with: hexane so pl. . PRI me R 3.) Cr-o-o (5 ml) in portions of chlorobenzene. The combined filter is evaporated in vacuo. A white crystalline substance is obtained with a mp. 107-110 ° C, yield 50, after recrystallization from hexane so pl. 110-112 C. Example t. C1 C1 -Q. SG C1 lov alcohol and dried. A white, crystalline, practically pure substance is obtained. , exit 75. After recrystallization from a mixture of toluene with hexane so pl. 17b-178 s. Froze
ОСКз О OSKz Oh
Ю)-о-с-о- Шг сНг са-о-с-оYu) -o-s-o-Shg CNG sa-o-s-o
Синтез осуществл ют в cooTBetciBHM с методикой, приведенной в 1римере t, с той разницей, мто вместо бис-хлорформиата 1,3-прбпандиола используют бис-хлорфррмиат t,З-бутандиола. Продукт выпадает из реакционного раствора в виде осадка вместе с сол нокисг The synthesis is carried out in cooTBetciBHM with the procedure given in example t, with the difference that it is used instead of bis-chloroformate 1,3-prbpandiol using bis-chlorofrmiate t, 3-butanediol. The product precipitates from the reaction solution as a precipitate along with hydroxys
ЧО)-о-с-о-снгсН2--си-о-с оCHO) -o-s-o-sngsN2 - C-o-s o
Синтез осуществл ют в соответствии 20 с методикой приведенной в примере 1, . с той разницей, что BMeicto бисхлорформиата 1 13-пропандиола используют бис-хлорформиат 1,3-бутандиола, аThe synthesis is carried out in accordance with the procedure described in Example 1,. with the difference that BMeicto bischloroformate 1 13-propanediol use bis-chloroformate 1,3-butanediol, and
вместо п-нитрофенола - пеНтахлорфенол 5 Продукт реакции в растворе, поэтому реакционную смесь отфильтровывают от выпавшего сол нокислого триэтиламина.instead of p-nitrophenol, petachlorophenol 5 The reaction product is in solution, therefore, the reaction mixture is filtered from the precipitated hydrochloric triethylamine.
лым триэтиламииом, осадок отфильтровывают , промывают этиловым спиртом и сушат. Получают белое, кристаллическое вещество с т.пл. , выход 6k%t после перекристаллизации из толуЬ а т.пл. l47-lA8 t, Синтез 6.solid triethylamiomy, the precipitate is filtered off, washed with ethyl alcohol and dried. A white, crystalline substance is obtained. , yield 6k% t after recrystallization from tolu and so pl. l47-lA8 t, Synthesis 6.
СНз ОSNZ Oh
I UI u
осадок промывают дважды небольшими порци ми по 5 мл хлорбензола. Объединенный фильтрат упаривают в вакууме. Получают белое, кристаллическое вещество с т.пл. 137-139 0, выход 72%, после перекристаллизации из Н-бутанола т.пл. UO-Ua С.the precipitate is washed twice with small portions of 5 ml of chlorobenzene. The combined filtrate was evaporated in vacuo. A white, crystalline substance is obtained. 137-139 0, yield 72%, after recrystallization from N-butanol so pl. UO-Ua S.
П р и м е р 7.PRI me R 7.
|0| 0
IIII
0-с- о-( о- с-00-с-о- (о- с-0
к раствору 0,76 г {П,01 моль) 1,3-пропандиола и 1,б2 мл (0,02 моль) безводного пиридина в 30 мл сухого тетрагидрофурана при охлаждении до добавл ют г (0,02 моль) хлорформиата Г)-нитрофенола. После добавлени всего количества хлорформиата охлаждение снимаюг и перемешиОto a solution of 0.76 g (P, 01 mol) of 1,3-propanediol and 1, B2 ml (0.02 mol) of anhydrous pyridine in 30 ml of dry tetrahydrofuran while cooling is added g (0.02 mol) of chloroformate G) -nitrophenol. After adding the total amount of chloroformate, cooling off and stirring
2лО/-о с-о(сН2)г сн-о-с-о- О)2лО / -о с-о (сН2) г sn-о-с-о-О)
Синтез осуществл ют в соответствии с методикой, приведенной в примере 7, с той разницей , что вместо 1,3-пропандиолаThe synthesis is carried out in accordance with the procedure given in example 7, with the difference that instead of 1,3-propanediol
вание продолжают при комнатной температуре в течение 2 ч. Выпавший осадок отфил ьтровывают, промывают этиловым спиртом и сушат. Т.пл. полученного вещества 130-132 С, выход 85, после перекристаллизации из толуола, т.пл. 132-133°С. Пример 8.Continue at room temperature for 2 hours. The precipitate formed is dried, washed with ethyl alcohol and dried. M.p. the obtained substance 130-132 C, yield 85, after recrystallization from toluene, so pl. 132-133 ° C. Example 8
СНч оSnch about
используют 1,3-бутандиол, т. пл. продукта , выход 82. После перекристаллизации из толуолаuse 1,3-butanediol, t. pl. product yield 82. After recrystallization from toluene
т.пл. , Основные А 71 132-133 1770 Толуол (перекристалА 65 88-90 1755 Толуол+гексан А 50 110-112 1765 Гексаи (перекристалА 75 176-178 1765 Толуол+гексаи А6. И7-1 8 1760- Толуол (перекристал1750 лизацией) . . (пЬемо) А72 1770 Н-бутанол (перё1780 криста лйзацией) (плв«ю) лизацией) (перекристаллизацией лизацией) (перекристаллизацией 7-в 750g характеристики активировэнмых бис-карбонатов общей формулы 50,16 3,23 6,61 (50.2«|)(3,)(6,9) «0,96 2,21 11,26 (1ц,13) (2,2) (11,29) 38,92 1,76 -Ю.Н ( 39,0) (1,,73) 3.78 ,0,76 -53,18 . (30,86) (0,91)-(53,7) 51,2« 3,68 6,58 (51 .««З) (3,81) (6,67) 31,92 V,02 -52,03 ( 32,0) (1,tS)152,6)m.p. , Basic A 71 132-133 1770 Toluene (recrystall A 65 88-90 1755 Toluene + hexane A 50 110-112 1765 Hexay (recrystall A 75 176-178 1765 Toluene + Hex A6. I7-1 8 1760- Toluene (by recrystallization 1750). . (pEmoo) A72 1770 N-butanol (before 1780 by crystallisation) (PLV) by lyse) (by recrystallization by crystallization) (by recrystallization of 7-in 750g characteristics of activated bis-carbonates of the general formula 50.16 3.23 6.61 (50.2 " |) (3,) (6.9) "0.96 2.21 11.26 (1st, 13) (2.2) (11.29) 38.92 1.76 - U.N (39.0 ) (1, 73) 3.78, 0.76 -53.18. (30.86) (0.91) - (53.7) 51.2 "3.68 6.58 (51." "H) (3.81) (6.67) 31.92 V, 02-52.03 (32.0) (1, tS) 152.6)
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU792810010A SU811750A1 (en) | 1979-08-07 | 1979-08-07 | Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU792810010A SU811750A1 (en) | 1979-08-07 | 1979-08-07 | Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
SU811750A1 true SU811750A1 (en) | 1983-09-23 |
Family
ID=20846453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU792810010A SU811750A1 (en) | 1979-08-07 | 1979-08-07 | Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU811750A1 (en) |
Cited By (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503538B1 (en) | 2000-08-30 | 2003-01-07 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US7304122B2 (en) | 2001-08-30 | 2007-12-04 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US7648727B2 (en) | 2004-08-26 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Methods for manufacturing a coated stent-balloon assembly |
US7648725B2 (en) | 2002-12-12 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US7682669B1 (en) | 2001-07-30 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device |
US7691401B2 (en) | 2000-09-28 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Poly(butylmethacrylate) and rapamycin coated stent |
US7699889B2 (en) | 2004-12-27 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide) block copolymers |
US7713637B2 (en) | 2006-03-03 | 2010-05-11 | Advanced Cardiovascular Systems, Inc. | Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US7749263B2 (en) | 2004-10-29 | 2010-07-06 | Abbott Cardiovascular Systems Inc. | Poly(ester amide) filler blends for modulation of coating properties |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US7766884B2 (en) | 2004-08-31 | 2010-08-03 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrophilic monomers |
US7772359B2 (en) | 2003-12-19 | 2010-08-10 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US7775178B2 (en) | 2006-05-26 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Stent coating apparatus and method |
US7776926B1 (en) | 2002-12-11 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for implantable medical devices |
US7785647B2 (en) | 2005-07-25 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Methods of providing antioxidants to a drug containing product |
US7785512B1 (en) | 2003-07-31 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices |
US7795467B1 (en) | 2005-04-26 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Bioabsorbable, biobeneficial polyurethanes for use in medical devices |
US7794743B2 (en) | 2002-06-21 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of making the same |
US7803394B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide hydrogel coatings for cardiovascular therapy |
US7803406B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US7807211B2 (en) | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US7807210B1 (en) | 2000-10-31 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Hemocompatible polymers on hydrophobic porous polymers |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
US7892592B1 (en) | 2004-11-30 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Coating abluminal surfaces of stents and other implantable medical devices |
US7976891B1 (en) | 2005-12-16 | 2011-07-12 | Advanced Cardiovascular Systems, Inc. | Abluminal stent coating apparatus and method of using focused acoustic energy |
US7985440B2 (en) | 2001-06-27 | 2011-07-26 | Advanced Cardiovascular Systems, Inc. | Method of using a mandrel to coat a stent |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US8007775B2 (en) | 2004-12-30 | 2011-08-30 | Advanced Cardiovascular Systems, Inc. | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
US8017140B2 (en) | 2004-06-29 | 2011-09-13 | Advanced Cardiovascular System, Inc. | Drug-delivery stent formulations for restenosis and vulnerable plaque |
US8021676B2 (en) | 2005-07-08 | 2011-09-20 | Advanced Cardiovascular Systems, Inc. | Functionalized chemically inert polymers for coatings |
US8029816B2 (en) | 2006-06-09 | 2011-10-04 | Abbott Cardiovascular Systems Inc. | Medical device coated with a coating containing elastin pentapeptide VGVPG |
US8052912B2 (en) | 2003-12-01 | 2011-11-08 | Advanced Cardiovascular Systems, Inc. | Temperature controlled crimping |
US8062350B2 (en) | 2006-06-14 | 2011-11-22 | Abbott Cardiovascular Systems Inc. | RGD peptide attached to bioabsorbable stents |
US8067025B2 (en) | 2006-02-17 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Nitric oxide generating medical devices |
US8067023B2 (en) | 2002-06-21 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Implantable medical devices incorporating plasma polymerized film layers and charged amino acids |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US8109904B1 (en) | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
US8110211B2 (en) | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US8147769B1 (en) | 2007-05-16 | 2012-04-03 | Abbott Cardiovascular Systems Inc. | Stent and delivery system with reduced chemical degradation |
US8173199B2 (en) | 2002-03-27 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US8192752B2 (en) | 2003-11-21 | 2012-06-05 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same |
US8293890B2 (en) | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
US8304012B2 (en) | 2006-05-04 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Method for drying a stent |
US8303651B1 (en) | 2001-09-07 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric coating for reducing the rate of release of a therapeutic substance from a stent |
US8357391B2 (en) | 2004-07-30 | 2013-01-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8506617B1 (en) | 2002-06-21 | 2013-08-13 | Advanced Cardiovascular Systems, Inc. | Micronized peptide coated stent |
US8568764B2 (en) | 2006-05-31 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Methods of forming coating layers for medical devices utilizing flash vaporization |
US8586069B2 (en) | 2002-12-16 | 2013-11-19 | Abbott Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
US8597673B2 (en) | 2006-12-13 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Coating of fast absorption or dissolution |
US8603634B2 (en) | 2004-10-27 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US8609123B2 (en) | 2004-11-29 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Derivatized poly(ester amide) as a biobeneficial coating |
US8647655B2 (en) | 2002-12-11 | 2014-02-11 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US8673334B2 (en) | 2003-05-08 | 2014-03-18 | Abbott Cardiovascular Systems Inc. | Stent coatings comprising hydrophilic additives |
US8685431B2 (en) | 2004-03-16 | 2014-04-01 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same |
US8703167B2 (en) | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
US8703169B1 (en) | 2006-08-15 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Implantable device having a coating comprising carrageenan and a biostable polymer |
US8741378B1 (en) | 2001-06-27 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device |
US8778014B1 (en) | 2004-03-31 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Coatings for preventing balloon damage to polymer coated stents |
US8778375B2 (en) | 2005-04-29 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Amorphous poly(D,L-lactide) coating |
US9028859B2 (en) | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
US9056155B1 (en) | 2007-05-29 | 2015-06-16 | Abbott Cardiovascular Systems Inc. | Coatings having an elastic primer layer |
US9102830B2 (en) | 2005-09-22 | 2015-08-11 | Medivas, Llc | Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
US9114198B2 (en) | 2003-11-19 | 2015-08-25 | Advanced Cardiovascular Systems, Inc. | Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same |
US9339592B2 (en) | 2004-12-22 | 2016-05-17 | Abbott Cardiovascular Systems Inc. | Polymers of fluorinated monomers and hydrocarbon monomers |
US9375445B2 (en) | 2004-06-18 | 2016-06-28 | Abbott Cardiovascular Systems Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US9517203B2 (en) | 2000-08-30 | 2016-12-13 | Mediv As, Llc | Polymer particle delivery compositions and methods of use |
US9561351B2 (en) | 2006-05-31 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Drug delivery spiral coil construct |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US9580558B2 (en) | 2004-07-30 | 2017-02-28 | Abbott Cardiovascular Systems Inc. | Polymers containing siloxane monomers |
US10076591B2 (en) | 2010-03-31 | 2018-09-18 | Abbott Cardiovascular Systems Inc. | Absorbable coating for implantable device |
-
1979
- 1979-08-07 SU SU792810010A patent/SU811750A1/en active
Cited By (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7807211B2 (en) | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US6503538B1 (en) | 2000-08-30 | 2003-01-07 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US7408018B2 (en) | 2000-08-30 | 2008-08-05 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US9517203B2 (en) | 2000-08-30 | 2016-12-13 | Mediv As, Llc | Polymer particle delivery compositions and methods of use |
US7691401B2 (en) | 2000-09-28 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Poly(butylmethacrylate) and rapamycin coated stent |
US7807210B1 (en) | 2000-10-31 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Hemocompatible polymers on hydrophobic porous polymers |
US8741378B1 (en) | 2001-06-27 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device |
US10064982B2 (en) | 2001-06-27 | 2018-09-04 | Abbott Cardiovascular Systems Inc. | PDLLA stent coating |
US7985440B2 (en) | 2001-06-27 | 2011-07-26 | Advanced Cardiovascular Systems, Inc. | Method of using a mandrel to coat a stent |
US7682669B1 (en) | 2001-07-30 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device |
US7304122B2 (en) | 2001-08-30 | 2007-12-04 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US8303651B1 (en) | 2001-09-07 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric coating for reducing the rate of release of a therapeutic substance from a stent |
US8173199B2 (en) | 2002-03-27 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US8961588B2 (en) | 2002-03-27 | 2015-02-24 | Advanced Cardiovascular Systems, Inc. | Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin |
US8506617B1 (en) | 2002-06-21 | 2013-08-13 | Advanced Cardiovascular Systems, Inc. | Micronized peptide coated stent |
US7875286B2 (en) | 2002-06-21 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US7901703B2 (en) | 2002-06-21 | 2011-03-08 | Advanced Cardiovascular Systems, Inc. | Polycationic peptides for cardiovascular therapy |
US8067023B2 (en) | 2002-06-21 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Implantable medical devices incorporating plasma polymerized film layers and charged amino acids |
US7803406B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US9084671B2 (en) | 2002-06-21 | 2015-07-21 | Advanced Cardiovascular Systems, Inc. | Methods of forming a micronized peptide coated stent |
US7794743B2 (en) | 2002-06-21 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of making the same |
US7803394B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide hydrogel coatings for cardiovascular therapy |
US8871236B2 (en) | 2002-12-11 | 2014-10-28 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US8986726B2 (en) | 2002-12-11 | 2015-03-24 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US7776926B1 (en) | 2002-12-11 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for implantable medical devices |
US8647655B2 (en) | 2002-12-11 | 2014-02-11 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US8871883B2 (en) | 2002-12-11 | 2014-10-28 | Abbott Cardiovascular Systems Inc. | Biocompatible coating for implantable medical devices |
US7648725B2 (en) | 2002-12-12 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US8586069B2 (en) | 2002-12-16 | 2013-11-19 | Abbott Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8673334B2 (en) | 2003-05-08 | 2014-03-18 | Abbott Cardiovascular Systems Inc. | Stent coatings comprising hydrophilic additives |
US9175162B2 (en) | 2003-05-08 | 2015-11-03 | Advanced Cardiovascular Systems, Inc. | Methods for forming stent coatings comprising hydrophilic additives |
US7785512B1 (en) | 2003-07-31 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices |
US9114198B2 (en) | 2003-11-19 | 2015-08-25 | Advanced Cardiovascular Systems, Inc. | Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same |
US8192752B2 (en) | 2003-11-21 | 2012-06-05 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same |
USRE45744E1 (en) | 2003-12-01 | 2015-10-13 | Abbott Cardiovascular Systems Inc. | Temperature controlled crimping |
US8052912B2 (en) | 2003-12-01 | 2011-11-08 | Advanced Cardiovascular Systems, Inc. | Temperature controlled crimping |
US7786249B2 (en) | 2003-12-19 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US7772359B2 (en) | 2003-12-19 | 2010-08-10 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US8685431B2 (en) | 2004-03-16 | 2014-04-01 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same |
US8778014B1 (en) | 2004-03-31 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Coatings for preventing balloon damage to polymer coated stents |
US9101697B2 (en) | 2004-04-30 | 2015-08-11 | Abbott Cardiovascular Systems Inc. | Hyaluronic acid based copolymers |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US8293890B2 (en) | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US9375445B2 (en) | 2004-06-18 | 2016-06-28 | Abbott Cardiovascular Systems Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US8017140B2 (en) | 2004-06-29 | 2011-09-13 | Advanced Cardiovascular System, Inc. | Drug-delivery stent formulations for restenosis and vulnerable plaque |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8758801B2 (en) | 2004-07-30 | 2014-06-24 | Abbott Cardiocascular Systems Inc. | Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages |
US8586075B2 (en) | 2004-07-30 | 2013-11-19 | Abbott Cardiovascular Systems Inc. | Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages |
US9580558B2 (en) | 2004-07-30 | 2017-02-28 | Abbott Cardiovascular Systems Inc. | Polymers containing siloxane monomers |
US8357391B2 (en) | 2004-07-30 | 2013-01-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages |
US7648727B2 (en) | 2004-08-26 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Methods for manufacturing a coated stent-balloon assembly |
US7766884B2 (en) | 2004-08-31 | 2010-08-03 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrophilic monomers |
US8110211B2 (en) | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US8603634B2 (en) | 2004-10-27 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US9067000B2 (en) | 2004-10-27 | 2015-06-30 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US7749263B2 (en) | 2004-10-29 | 2010-07-06 | Abbott Cardiovascular Systems Inc. | Poly(ester amide) filler blends for modulation of coating properties |
US8609123B2 (en) | 2004-11-29 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Derivatized poly(ester amide) as a biobeneficial coating |
US7892592B1 (en) | 2004-11-30 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Coating abluminal surfaces of stents and other implantable medical devices |
US9339592B2 (en) | 2004-12-22 | 2016-05-17 | Abbott Cardiovascular Systems Inc. | Polymers of fluorinated monomers and hydrocarbon monomers |
US7699889B2 (en) | 2004-12-27 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide) block copolymers |
US8007775B2 (en) | 2004-12-30 | 2011-08-30 | Advanced Cardiovascular Systems, Inc. | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
US7795467B1 (en) | 2005-04-26 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Bioabsorbable, biobeneficial polyurethanes for use in medical devices |
US8778375B2 (en) | 2005-04-29 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Amorphous poly(D,L-lactide) coating |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
US8021676B2 (en) | 2005-07-08 | 2011-09-20 | Advanced Cardiovascular Systems, Inc. | Functionalized chemically inert polymers for coatings |
US7785647B2 (en) | 2005-07-25 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Methods of providing antioxidants to a drug containing product |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US9102830B2 (en) | 2005-09-22 | 2015-08-11 | Medivas, Llc | Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US7976891B1 (en) | 2005-12-16 | 2011-07-12 | Advanced Cardiovascular Systems, Inc. | Abluminal stent coating apparatus and method of using focused acoustic energy |
US8067025B2 (en) | 2006-02-17 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Nitric oxide generating medical devices |
US7713637B2 (en) | 2006-03-03 | 2010-05-11 | Advanced Cardiovascular Systems, Inc. | Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US8304012B2 (en) | 2006-05-04 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Method for drying a stent |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US7775178B2 (en) | 2006-05-26 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Stent coating apparatus and method |
US9561351B2 (en) | 2006-05-31 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Drug delivery spiral coil construct |
US8568764B2 (en) | 2006-05-31 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Methods of forming coating layers for medical devices utilizing flash vaporization |
US8703167B2 (en) | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
US8778376B2 (en) | 2006-06-09 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating |
US8029816B2 (en) | 2006-06-09 | 2011-10-04 | Abbott Cardiovascular Systems Inc. | Medical device coated with a coating containing elastin pentapeptide VGVPG |
US8118863B2 (en) | 2006-06-14 | 2012-02-21 | Abbott Cardiovascular Systems Inc. | RGD peptide attached to bioabsorbable stents |
US8062350B2 (en) | 2006-06-14 | 2011-11-22 | Abbott Cardiovascular Systems Inc. | RGD peptide attached to bioabsorbable stents |
US8114150B2 (en) | 2006-06-14 | 2012-02-14 | Advanced Cardiovascular Systems, Inc. | RGD peptide attached to bioabsorbable stents |
US9028859B2 (en) | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
US8703169B1 (en) | 2006-08-15 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Implantable device having a coating comprising carrageenan and a biostable polymer |
US8597673B2 (en) | 2006-12-13 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Coating of fast absorption or dissolution |
US8147769B1 (en) | 2007-05-16 | 2012-04-03 | Abbott Cardiovascular Systems Inc. | Stent and delivery system with reduced chemical degradation |
US9056155B1 (en) | 2007-05-29 | 2015-06-16 | Abbott Cardiovascular Systems Inc. | Coatings having an elastic primer layer |
US8109904B1 (en) | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
US10076591B2 (en) | 2010-03-31 | 2018-09-18 | Abbott Cardiovascular Systems Inc. | Absorbable coating for implantable device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU811750A1 (en) | Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same | |
RU2674343C2 (en) | 2-oxo-1,3-dioxolane-4-carboxamide building blocks, preparation and use thereof | |
JPS61501089A (en) | Cyclic disulfonic acid ester compounds | |
CA1340884C (en) | Radiation-sensitive, ethylenically unsaturated, copolymerizable compounds and their preparation | |
EP0511948A2 (en) | Preparation of urethane and carbonate products | |
US3627813A (en) | A process of preparing carbamates | |
JPH0745437B2 (en) | Method for producing ester | |
JPS5934171B2 (en) | Production method of bisphenol A polyalkyl carbonate ester | |
US3211774A (en) | Process for preparing aromatic esters of chloroformic acid | |
Distaso et al. | Group 3 metal (Sc, La) triflates as catalysts for the carbomethoxylation of aliphatic amines with dimethylcarbonate under mild conditions | |
EP0508430B1 (en) | Process for the preparation of bisoxazolidines containing urethane groups | |
US4381404A (en) | Process for the production of N,O-disubstituted urethanes and use thereof as starting materials for the production of organic isocyanates | |
ITMI951446A1 (en) | PROCEDURE FOR THE PRODUCTION OF AROMATIC URETANS | |
US4137253A (en) | Preparation of chloroformates having terminal acrylic or methacrylic groups | |
JPS62289554A (en) | Novel hydroxyphenylurethanes, manufacture and use | |
US3769319A (en) | N-ethyl-n-(1 - (m-trifluoromethylphenyl)-propyl-(2))-carbamic acid ethyl ester | |
US4851550A (en) | Process for the preparation of cyclic aliphatic orthocarbonic esters new cyclic orthocarbonic esters | |
US3094538A (en) | Carbonatopropyl dicarbamates | |
US3079302A (en) | O[n-di-(chloroalkyl)carbamoyl] serine | |
JPS6226251A (en) | Manufacture of bischloroformate composition | |
KR100219994B1 (en) | Glyceraldehyde-3-pentanide and process for producing same | |
US3092656A (en) | Method of manufacturing nu-substituted 2, 2-disubstituted-1, 3-propanediol dicarbamate | |
JP3851990B2 (en) | Method for producing acryloylcarbamate | |
EP0556538A1 (en) | Blocked tricarbamate compounds | |
US3472889A (en) | Aminonitriles |